Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dyamed Biotech is a Singapore-based medical device and solution distributor, primarily focused on wound care, scar reduction, and eczema management in Southeast Asia. The company commercializes products like Dermacyn® Wound Care, Dermacyn® Scarless, and Dermacyn® Ezyma Spray through a long-term partnership with Sonoma Pharmaceuticals, leveraging their hypochlorous acid-based technologies. Dyamed does not engage in original drug discovery or clinical development, but instead specializes in expanding market access for clinically validated medical devices, with plans to launch additional products in eye (Ocucyn®) and oral (Oracyn®) care markets in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dyamed Biotech.